iBio, Inc. Common Stock
Symbol: IBIO (NASDAQ)
0.86
▲ (3.63%) 0.030
Company Description:
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Key Stats
- Today's Open: $0.83
- Today's High: $0.89
- Today's Low: $0.771
- Today's Volume: 729.93K
- Yesterday Close: $0.8328
- Yesterday High: $0.8692
- Yesterday Low: $0.8211
- Yesterday Volume: 370.08K
- Last Min Volume: 3
- Last Min High: $0.863
- Last Min Low: $0.863
- Last Min VWAP: $0.863
Company Profile
- Name: iBio, Inc. Common Stock
- Website: https://www.ibioinc.com
- Listed Date: 2008-08-19
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001420720
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $16.80M
- Round Lot: 100
- Outstanding Shares: 19.65M
- Asset Type: CS
RECENT FILINGS FOR IBIO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 10-K | View |
| 2025-09-05 | 8-K | View |
| 2025-08-26 | SCHEDULE 13G | View |
| 2025-08-25 | SCHEDULE 13G | View |
| 2025-08-21 | 8-K | View |
| 2025-08-21 | 424B5 | View |
| 2025-08-18 | 8-K | View |
| 2025-08-18 | 424B5 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-01 | 8-K | View |
| 2025-07-30 | SCHEDULE 13G/A | View |
| 2025-06-24 | 424B3 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-23 | EFFECT | View |
| 2025-06-18 | CORRESP | View |
| 2025-06-18 | UPLOAD | View |
| 2025-06-18 | 8-K | View |
| 2025-06-13 | S-3 | View |
| 2025-05-07 | D | View |
| 2025-05-02 | 10-Q | View |
Latest News on IBIO